ArticleESMO open2019

Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer.

Victor Rodriguez-Freixinos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.